Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901. (Q46516706)
Jump to navigation
Jump to search
scientific article published in June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901. |
scientific article published in June 2005 |
Statements
1 reference
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901. (English)
1 reference
Mark J Ratain
1 reference
Eric Small
1 reference
Walter M Stadler
1 reference
Gary Rosner
1 reference
Donna Hollis
1 reference
Brian Rini
1 reference
S Donald Zaentz
1 reference
John Mahoney
1 reference
1 June 2005
1 reference
23
1 reference
16
1 reference
3726-3732
1 reference